๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Chemical and hematological screening in patients with malignant and non-malignant conditions

โœ Scribed by Dr. Yeu-Tsu N. Lee; Hubert J. Van Peenen; Francis R. Watson

Publisher
John Wiley and Sons
Year
1980
Tongue
English
Weight
483 KB
Volume
15
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Diagnosis and treatment of fungal infect
Diagnosis and treatment of fungal infections in patients with hematologic malignancies
โœ F. Radaelli; A. Cortelezzi; L. Zocchi; D. Castagnone; L. Baldini; M. Colombi; R. ๐Ÿ“‚ Article ๐Ÿ“… 1986 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 442 KB

A diagnosis of deep-seated mycosis was made in 54 patients with hematologic malignancies, severe neutropenia and fever, based on a set of clinical and laboratory criteria. Standardized antifungal treatment was started in 31 patients who seven days after onset of fever had not responded to antibiotic

Outcome predictors of 84 patients with h
Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection
โœ Marcio Nucci; Elias J. Anaissie; Flavio Queiroz-Telles; Carlos A. Martins; Plรญni ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 83 KB

## Abstract ## BACKGROUND Invasive infection by __Fusarium__ sp. is associated with high mortality in patients with hematologic cancer. Yet to the authors' knowledge, little is known regarding predictors of adverse outcome. ## METHODS The authors conducted a retrospective review of the records o

Epoetin alfa corrects anemia and improve
Epoetin alfa corrects anemia and improves quality of life in patients with hematologic malignancies receiving non-platinum chemotherapy
โœ Timothy J. Littlewood; Johan Nortier; Bernardo Rapoport; Marek Pawlicki; Gilbert ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 128 KB

Anemia, a commonly occurring morbidity in patients with cancer, often leads to diminished quality of life (QOL). Numerous clinical trials have shown that epoetin alfa treatment improves hematologic and QOL variables in cancer patients. The clinical trial analysis reported here was performed to asses